酶抑制剂:对最近获得专利的化合物的审查 (2016-2023)
Shivani Kasana1, Shivam Kumar1, Preeti Patel1
1Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, India.
Expert opinion on therapeutic patents
|August 29, 2024
概括
本综述详细介绍了2016-2023年期间获得专利的近期卡斯巴酶抑制剂,涵盖和非类型. 这些抑制剂为与失调的酶活性相关的疾病提供了潜在的治疗策略.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 卡斯帕酶是调节细胞亡 (编程细胞死亡) 的关键蛋白酶.
- 失调的酶活性与许多疾病有关,包括神经退行性和自身免疫性疾病.
- 准caspases是开发新疗法的关键策略.
研究的目的:
- 为最近获得专利的酶抑制剂 (2016-2023) 提供全面的审查.
- 分析这些抑制剂在各种疾病中的治疗应用.
- 突出了解酶抑制剂机制和结构的进展.
主要方法:
- 从2016年到2023年对专利文献进行系统审查.
- 专利的酶抑制剂 (和非) 的分类和分析.
- 检查疾病点和已识别的抑制剂的治疗相关性.
主要成果:
- 新型和非类卡斯巴酶抑制剂的识别和分类.
- 对专利抑制剂在治疗神经退行性和自身免疫性疾病等疾病中的应用范围的分析.
- 对最近获得专利的化合物的结构和机制见解的综合.
结论:
- 最近的专利揭示了在开发向酶抑制剂方面取得的重大进展.
- 专利的卡斯巴酶抑制剂在治疗与异常亡相关的疾病方面表现有前途.
- 本综述是研究人员和开发人员在卡斯巴酶向疗法领域的关键资源.
相关概念视频
Caspases
12.4K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.4K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
499
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
499


